The pharmacokinetics of VIP in dog and pig
โ Scribed by S. J. Mitchell; I. M. Modlin; A. A. J. D'Sa Barros; S. R. Bloom
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 338 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive
The pharmacokinetics of 8-MOP were studied in six dogs following intravenous administration of 2 mg kg-'. In most animals a bi-exponential decline of the plasma level profile was observed. The calculated pharmacokinetic parameters varied considerably between the different dogs. The mean half-lives o
The kinetic behaviour of the aminoglycoside aminosidine, given at 15 mg/kg intravenously, intramuscularly and subcutaneously, was studied in 5 dogs to determine the appropriate dosage schedule. The pharmacokinetic behaviour of aminosidine in dogs was similar to that in other species, except that it